Our Mission
Vivorté’s mission is to identify, develop and commercialize innovative orthopedic devices to improve the lives of patients. Vivorté’s focus is to maintain or improve bone strength while expediting the healing process. The company’s firm commitment to providing high quality, unique technologies to better suit market needs drives the ongoing development of cost effective solutions for patients, surgeons, hospitals and payers.
Quality Assurance
Our Commitment
We are committed to delivering safe, effective, and reliable orthopedic solutions that meet the highest standards of quality and regulatory compliance. Quality is embedded throughout every stage of our product lifecycle—from initial design and development to manufacturing and post-market monitoring.
Regulatory Compliance
Our Quality System is built on rigorous, internationally recognized standards for medical device quality. We maintain compliance with ISO 13485 and FDA 21 CFR Part 820, integrate risk management throughout our processes (ISO 14971), and follow GMP- and GTP-aligned practices to ensure the safety and performance of our products.
Manufacturing Excellence
We deliver orthopedic solutions through precision-controlled manufacturing. Our products are produced in cleanroom environments to ensure sterility and consistency. All packaging and labeling are performed in-house, providing complete traceability and regulatory compliance. Our tissue processing operations follow stringent Good Tissue Practices to ensure the safe handling of biologic materials. Every batch undergoes rigorous in-process and final product testing, supported by validated processes and continuous improvement initiatives.
Where Heritage Meets Innovation
Located at 1044 E. Chestnut Street in Louisville, Kentucky, our headquarters resides within a remarkable 150+ year-old building that reflects the city’s industrial and entrepreneurial heritage. Originally constructed in 1867 as the Eclipse Woolen Mill shortly after the Civil War, the facility employed hundreds of workers producing durable denim for “Kentucky Jeans,” a staple for 19th-century farmers and laborers. In 1915, the property was transformed into a hub for construction materials as part of American Builders Supply Co., and later adapted for use by a railway signal company serving the rapidly expanding rail network. Over time, the building evolved into medical device and pharmaceutical manufacturing spaces, all while preserving its distinctive Victorian industrial architecture, including its iconic towers and dormer windows. Today, following a thoughtful 21st-century adaptive reuse renovation, the building stands as a modern home for innovation – supporting Louisville’s growing life sciences community while honoring its rich past.
Board of Directors
Ruth Voor
Co-Founder
Board of Directors
Ruth worked for more than 18 years at Johnson & Johnson. Ms. Voor was the Executive Director of Drug Eluting Stent Commercialization for J&J, leading the team that took CYPHER® Drug Eluting Stent from concept to launch and global approval in less than 4 years, achieving $1B in US sales in the first 9 months.
Michael Voor, PhD
Co-Founder, Chief Science Officer
Acting President/CEO
Dr. Voor is the Director of the Orthopaedic Bioengineering Laboratory at the University of Louisville. He has over 60 peer-reviewed publications, has secured over $3M in research funding and consulted on projects with many large orthopedic companies. Dr. Voor has authored several patents and has a bone fixation device, which is sold by DePuy Spine, Inc.
Arnold-Peter Weiss, M.D.
Board of Directors
Arnold-Peter C. Weiss, M.D. is a hand surgeon with University Orthopedics in Providence. He received his B.A. and M.D. degrees from Johns Hopkins University, completed an orthopedic surgery residency at Johns Hopkins Hospital, and a hand surgery fellowship at the Indiana Hand Center. He is currently the R. Scot Sellers Scholar of Hand Surgery, Vice Chairman and Professor at Brown Medical School. He holds 10 US patents on orthopedic joint implants and devices used worldwide.
Robert Saunders
Board of Directors
Mr. Saunders currently serves as a General Partner of OCA Ventures and is a Founding Partner of Saunders Murdock & Associates, specializing in life science and technology investments.
Previously, Saunders served as Senior Managing Director of Chrysalis Ventures. He was additionally a founding board member of MetaCyte Business Lab, a life science incubator at the University of Louisville.
Tyree Wilburn
Board of Directors
Mr. Wilburn is Chairman of the Board, President and Chief Executive Officer of Merit Health Systems, LLC, a private hospital management company.
Wilburn was Chief Development Officer of Community Health Systems, Inc., and, most recently, Executive Vice President and Chief Financial and Development Officer.
Mr. Wilburn has additionally held held senior and executive positions in mergers and acquisitions, finance, planning, hospital operations, audit and investor relations with Humana Inc.
B.J. Scheessele
Board of Directors
Mr. Scheessele is an innovative leader with 20 years of experience creating and growing new businesses in high-growth medical device companies.
Scheessele holds a focus on building a commercial team culture that supports business objectives, sales growth and market sales goals while significantly enhancing enterprise value.
GFS-00034-07